BMEA

Biomea Fusion Inc · NASDAQ

Sector Health Technology
Industry Pharmaceuticals: Major
Website biomeafusion.com
Employees(FY) 103
ISIN US09077A1060

Performance

+6.84%

+42.22%

+126.95%

-15.52%

-25.76%

YTD

-5.36%

Profile

Biomea Fusion, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of covalent small molecule drugs to treat patients with genetically defined cancers and metabolic diseases. Its lead product candidate is BMF-219, an orally bioavailable, potent, and selective covalent inhibitor of menin for treating patients with liquid and solid tumors and type 2 diabetes. Biomea Fusion, Inc. was incorporated in 2017 and is headquartered in Redwood City, California.

Advanced Technical Analysis

Technical Analysis of BMEA 2024-10-11

The stock exhibits a bullish sentiment overall, driven by a strong Moving Average Score of 76, while the Technical Score of 63 further supports this positive outlook; however, the neutral Oscillators Score of 50 suggests a potential consolidation phase that investors should monitor closely.

Technical Scores and Rating

Moving Average Score

Oscillator Score

Technical Rating

Stock Analysis of BMEA

Stock Rank

Recent News & Updates

2024-10-09 20:57
Morning Movers: Arcadium Lithium surges after deal to be acquired(Yahoo Finance)
2024-10-06 21:00
Biomea Fusion to Present at the 1st Annual Asian Conference on Innovative Therapies for Diabetes Management (ATTD-ASIA 2024)(Globenewswire)
2024-09-30 21:00
Biomea Announces Formation of Global Scientific Advisory Board with 22 World-Renowned Diabetes Experts(Globenewswire)
2024-09-27 00:20
FDA Removes Clinical Hold On Biomea Fusion's Early-Stage Trials For Potential Diabetes Candidate(Yahoo Finance)
2024-09-26 23:13
Biomeas stock bounces back as FDA lifts clinical hold on diabetes trials(Yahoo Finance)
2024-09-26 02:00
FDA Lifts Clinical Hold on BMF-219 in Type 2 and Type 1 Diabetes Trials(Globenewswire)
2024-08-13 21:55
Wall Street Analysts Think Biomea Fusion (BMEA) Could Surge 317.86%: Read This Before Placing a Bet(Yahoo Finance)
2024-08-01 04:05
Biomea Fusion, Inc. Reports Inducement Grant under Nasdaq Listing Rule 5635(c)(4)(Globenewswire)
2024-07-31 10:54
BMEA Stock Earnings: Biomea Fusion Beats EPS for Q2 2024(Investorplace)
2024-07-31 04:05
Biomea Fusion Reports Second Quarter 2024 Financial Results and Corporate Highlights(Globenewswire)
2024-06-29 08:32
Biomea Fusion, Inc. (BMEA): Why Did Analysts Give This Biotech Penny Stock a Moderate Buy Rating?(Insidermonkey)
2024-06-29 06:30
10 Best Biotech Penny Stocks to Buy Now(Insidermonkey)
2024-06-27 14:21
Why Are Hedge Funds Shorting Biomea Fusion, Inc. (BMEA)?(Insidermonkey)
2024-06-26 11:08
What Is Short Selling In Stock Market? 15 Stocks Hedge Funds are Shorting(Insidermonkey)
2024-06-16 21:00
Acute Myeloid Leukemia is on the Rise as Biotechs Race to Develop Groundbreaking Therapies(Globenewswire)
2024-06-10 23:34
Biomea Fusion, Inc. (NASDAQ:BMEA) Downgraded by Barclays(Yahoo Finance)
2024-06-10 21:06
Analysts on Wall Street Lower Ratings for These 10 Stocks(Insidermonkey)
2024-06-07 04:23
Biomea Fusion Crashes 63% After FDA Puts Diabetes Treatment Studies On Hold(Yahoo Finance)
2024-06-06 20:56
Biomea Fusion Crashes 65% After FDA Puts Diabetes Treatment Studies On Hold(Yahoo Finance)
2024-06-06 20:16
Why Is Biomea Fusion (BMEA) Stock Down 63% Today?(Investorplace)
2024-06-06 19:22
Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday(Investorplace)
2024-06-06 18:17
Ride the Gamma Wave: 3 Stocks on the Verge of a Short Squeeze(Investorplace)
2024-06-06 16:25
FDA places full clinical hold on Biomea Fusions diabetes trials of BMF-219(Yahoo Finance)
2024-06-06 04:05
Biomea Fusion Announces BMF-219 in Diabetes Placed on Clinical Hold(Globenewswire)
2024-06-06 01:14
Short Squeeze Specialists: 3 Stocks With the Expertise to Defy Bearish Expectations(Investorplace)
2024-06-03 04:05
Biomea Fusion, Inc. Reports Inducement Grant under Nasdaq Listing Rule 5635(c)(4)(Globenewswire)
2024-05-29 21:12
Biomea Fusion Announces Completion of Enrollment of First 3 Arms in Phase 2 Expansion Cohorts of COVALENT-111 Study for BMF-219 in Type 2 Diabetes(Globenewswire)
2024-05-02 16:05
Biomea Fusion Reports First Quarter 2024 Financial Results and Corporate Highlights(GlobeNewswire)
2024-05-02 10:54
BMEA Stock Earnings: Biomea Fusion Misses EPS for Q1 2024(Investorplace)
2024-05-02 04:05
Biomea Fusion Reports First Quarter 2024 Financial Results and Corporate Highlights(Globenewswire)

Page 1 of 6

previousnext

Disclaimer: The information provided here and on kavout.com site is for general informational purposes only. It does not constitute investment advice, financial advice, trading advice, or any other sort of advice. Kavout does not recommend that any investment decision be made based on this information. You are solely responsible for your own investment decisions. Please conduct your own research and consult with qualified financial advisors before making any investment.